The effects of lowering nighttime and breakfast glucose levels with sensor-augmented pump therapy on hemoglobin A1c levels in type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 16, Issue 5, 2014, Pages 284-291

  Maahs, David M ^a   Chase, H Peter ^a   Westfall, Emily ^a   Slover, Robert ^a   Huang, Suiying ^b   Shin, John J ^b   Kaufman, Francine R ^b   Pyle, Laura ^c   Snell Bergeon, Janet K ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b Medtronic   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSOR AUGMENTED PUMP; ADOLESCENT; AGED; BLOOD; CHILD; DIABETES MELLITUS, TYPE 1; INSULIN INFUSION; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; STATISTICAL MODEL; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BREAKFAST; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 84899077873     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0227     Document Type: Article

References (15)

1. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA: The T1D Exchange clinic registry. J Clin Endocrinol Metab 2012;97:4383-4389.
2. The effect of intensive treatment of diabetes on the development and progression of long-Term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
3. Bastyr EJ III, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE: Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group. Diabetes Care 2000;23:1236-1241.
4. Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA1c. Diabetes Care 2003; 26:881-885.
5. Riddle M, Umpierrez G, DiGenio A, Zhou R, Rosenstock J: Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes. Diabetes Care 2011;34: 2508-2514.
6. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA: Effectiveness of sensoraugmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
7. Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV: Effectiveness of sensoraugmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes 2012; 13:6-11.
8. American Diabetes Association: Standards of medical care in diabetes-2013. Diabetes Care 2013;36(Suppl 1):S11-S66.
9. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833.
10. Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G, Jasinskiene E, De Block C, Carrette O, Castañeda J, Cohen O: Routine sensor-Augmented pump therapy in type 1 diabetes: The INTERPRET study. Diabetes Technol Ther 2013;15:273-280.
11. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ: Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478.
12. Wilson DM, Xing D, Cheng J, Beck RW, Hirsch I, Kollman C, Laffel L, Lawrence JM, Mauras N, Ruedy KJ, Tsalikian E, Wolpert H: Persistence of individual variations in glycated hemoglobin: Analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial. Diabetes Care 2011;34:1315-1317.
13. Wilson DM, Xing D, Beck RW, Block J, Bode B, Fox LA, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Steffes M, Tamborlane WV: Hemoglobin A1c and mean glucose in patients with type 1 diabetes: Analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care 2011;34:540-544.
14. Wilson DM, Kollman: Relationship of A1C to glucose concentrations in children with type 1 diabetes: Assessments by high-frequency glucose determinations by sensors. Diabetes Care 2008;31:381-385.
15. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR: Associations between features of glucose exposure and A1C: The A1C-Derived Average Glucose (ADAG) study. Diabetes 2010;59:1585-1590.